270 related articles for article (PubMed ID: 33550691)
1. Metformin as a potential protective therapy against tuberculosis in patients with diabetes mellitus: A retrospective cohort study in a single teaching hospital.
Fu CP; Lee CL; Li YH; Lin SY
J Diabetes Investig; 2021 Sep; 12(9):1603-1609. PubMed ID: 33550691
[TBL] [Abstract][Full Text] [Related]
2. Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study.
Lee MC; Lee CH; Lee MR; Wang JY; Chen SM
BMC Infect Dis; 2019 Nov; 19(1):936. PubMed ID: 31694558
[TBL] [Abstract][Full Text] [Related]
3. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
[TBL] [Abstract][Full Text] [Related]
4. Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria.
Lee MC; Chiang CY; Lee CH; Ho CM; Chang CH; Wang JY; Chen SM
PLoS One; 2018; 13(10):e0205807. PubMed ID: 30335800
[TBL] [Abstract][Full Text] [Related]
5. The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus.
Heo E; Kim E; Jang EJ; Lee CH
BMC Pulm Med; 2021 Sep; 21(1):303. PubMed ID: 34563159
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of metformin against tuberculosis infections in diabetic patients: an observational study of south Indian tertiary healthcare facility.
Marupuru S; Senapati P; Pathadka S; Miraj SS; Unnikrishnan MK; Manu MK
Braz J Infect Dis; 2017; 21(3):312-316. PubMed ID: 28199824
[TBL] [Abstract][Full Text] [Related]
7. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy.
Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Hissar S; Kornfeld H; Babu S
BMC Infect Dis; 2019 Dec; 19(1):1039. PubMed ID: 31818258
[TBL] [Abstract][Full Text] [Related]
8. Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment.
Degner NR; Wang JY; Golub JE; Karakousis PC
Clin Infect Dis; 2018 Jan; 66(2):198-205. PubMed ID: 29325084
[TBL] [Abstract][Full Text] [Related]
9. Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes.
Mily A; Sarker P; Taznin I; Hossain D; Haq MA; Kamal SMM; Agerberth B; Brighenti S; Raqib R
BMC Infect Dis; 2020 Dec; 20(1):933. PubMed ID: 33287713
[TBL] [Abstract][Full Text] [Related]
10. Metformin promotes smear conversion in tuberculosis-diabetes comorbidity and construction of prediction models.
Wang Y; Zhou Y; Chen L; Cheng Y; Lai H; Lyu M; Zeng J; Zhang Y; Feng P; Ying B
J Clin Lab Anal; 2022 Dec; 36(12):e24755. PubMed ID: 36347820
[TBL] [Abstract][Full Text] [Related]
11. Renal function markers and metformin eligibility.
Tavares Bello C; Castro Fonseca R; Sousa Santos F; Sequeira Duarte J; Azinheira J; Vasconcelos C
Minerva Endocrinol; 2018 Sep; 43(3):246-252. PubMed ID: 28565889
[TBL] [Abstract][Full Text] [Related]
12. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
[TBL] [Abstract][Full Text] [Related]
13. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar.
Al-Shaer MH; Elewa H; Alkabab Y; Nazer LH; Heysell SK
BMC Infect Dis; 2018 Aug; 18(1):384. PubMed ID: 30089476
[TBL] [Abstract][Full Text] [Related]
14. The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus.
Lee YJ; Han SK; Park JH; Lee JK; Kim DK; Chung HS; Heo EY
Korean J Intern Med; 2018 Sep; 33(5):933-940. PubMed ID: 29540054
[TBL] [Abstract][Full Text] [Related]
15. Long-term metformin use and risk of pneumonia and related death in type 2 diabetes: a registry-based cohort study.
Yang A; Shi M; Wu H; Lau ESH; Ma RCW; Kong APS; So WY; Luk AOY; Chan JCN; Chow E
Diabetologia; 2021 Aug; 64(8):1760-1765. PubMed ID: 33844069
[TBL] [Abstract][Full Text] [Related]
16. Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus.
Lin HC; Stein JD; Nan B; Childers D; Newman-Casey PA; Thompson DA; Richards JE
JAMA Ophthalmol; 2015 Aug; 133(8):915-23. PubMed ID: 26022641
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia.
Magee MJ; Kempker RR; Kipiani M; Gandhi NR; Darchia L; Tukvadze N; Howards PP; Narayan KM; Blumberg HM
Int J Tuberc Lung Dis; 2015 Jun; 19(6):685-92. PubMed ID: 25946360
[TBL] [Abstract][Full Text] [Related]
18. The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus.
Amador-Licona N; Guízar-Mendoza J; Vargas E; Sánchez-Camargo G; Zamora-Mata L
Arch Med Res; 2000; 31(6):571-5. PubMed ID: 11257323
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness of Second-Line Agents for the Treatment of Diabetes Type 2 in Preventing Kidney Function Decline.
Hung AM; Roumie CL; Greevy RA; Grijalva CG; Liu X; Murff HJ; Ikizler TA; Griffin MR
Clin J Am Soc Nephrol; 2016 Dec; 11(12):2177-2185. PubMed ID: 27827311
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R
Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
